Evofosfamide
Biological
EMD Serono Research & Development Institute
Total Payments
$175,530
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $175,530 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $175,530 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| EMR 200592-006 | EMD Serono Research & Development Institute | $175,530 | 0 |
Top Doctors Receiving Payments for Evofosfamide
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Philadelphia, PA | $175,530 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Biological
- Total Payments $175,530
- Total Doctors 0
- Transactions 1
About Evofosfamide
Evofosfamide is a biological associated with $175,530 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is EMD Serono Research & Development Institute.
Payment data is available from 2017 to 2017. In 2017, $175,530 was paid across 1 transactions to 0 doctors.
The most common payment nature for Evofosfamide is "Unspecified" ($175,530, 100.0% of total).
Evofosfamide is associated with 1 research study, including "EMR 200592-006" ($175,530).